Keyword: UnitedHealth Group
UnitedHealthcare is making demands about pharma's new strategy to lower prices, an analyst wrote.
UnitedHealthcare's pharmacy benefits outfit OptumRx picked Amgen and Eli Lilly CGRP drugs for its preferred coverage list, handing Teva a setback.
Thanks to groundwork laid by the feds, UnitedHealthcare is suing dozens of generics companies for alleged price fixing—and it wants its money back.
Jockeying for market share, Eli Lilly offered more than half off its U.S. list prices in the form of rebates and discounts last year.
In the wake of the Aetna-CVS combo, Cigna's Express Scripts buy could mean more pricing resistance ahead for drugmakers.
UnitedHealthcare is planning to offer rebates directly back to millions of patients—a move that addresses a top criticism from the drug industry.
California Gov. Jerry Brown signed a new regulation limiting copay couponing, dealing a second key loss for the industry in the state.
Will Amazon shake up pharma just as it's upturning the grocery business? Industry watchers are scrying a steady drip-drip-drip of leaking info.
Lantus has led the way, both in diabetes sales and in Sanofi sales, for years now, pumping out more than $7 billion worldwide for the company at its peak. But now, for the second year in a row, sales of Lantus dropped year over year in 2016.
Readers are full of surprises. Sometimes, stories we editors put on top of the news don’t make the cut with readers. Others are unexpected hits. Still others resurface from the past. Find all three in this year's roundup of 2016 news curated by you, our readers.